NCT01925872

Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance

The Optimal Regimen of Medical Treatment in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Zhongrong Miao · Academic / Other
• Sex: All
• Age: 25 Years – 95 Years
• Healthy volunteers: Not accepted

Summary

1. Clopidogrel resistance is common in patients of ischemic cerebrovascular disease. 2. Genetic polymorphisms are the most important factors to clopidogrel resistance. 3. The purpose of this study is to find the genes which are the related to clopidogrel resistance. 4. Through gene sequencing, we can filter patient of clopidogrel resistance, so another drug maybe used to avoid the undesired efficacy.

Conditions

• Ischemic Cerebrovascular Disease

Timeline

• Start date: 2013-05-01
• Primary completion: 2015-05-01
• Completion: 2015-05-01
• First posted: 2013-08-20
• Last updated: 2015-01-28